Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
about
Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake.Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implicationsLipidomic and spatio-temporal imaging of fat by mass spectrometry in mice duodenum during lipid digestionGenetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly.NPC1L1 and cholesterol transportCholesterol, the central lipid of mammalian cellsCholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice.Epigenetic regulation of cholesterol homeostasis.Evaluation of vehicle substances on vitamin D bioavailability: a systematic review.Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records.Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbersEffects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol.Impact of physiological levels of chenodeoxycholic acid supplementation on intestinal and hepatic bile acid and cholesterol metabolism in Cyp7a1-deficient mice.Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats.The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.Modelling approach to simulate reductions in LDL cholesterol levels after combined intake of statins and phytosterols/-stanols in humans.Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytesRecent advances in small bowel diseases: Part II.Association of rs2072183 SNP and serum lipid levels in the Mulao and Han populations.Fluorescent mimics of cholesterol that rapidly bind surfaces of living mammalian cells.Flotillin-2 Gene Is Associated with Coronary Artery Disease in Chinese Han PopulationSustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events.Therapies targeting exogenous cholesterol uptake: new insights and controversies.A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot?Quantitation of the rates of hepatic and intestinal cholesterol synthesis in lysosomal acid lipase-deficient mice before and during treatment with ezetimibe.Hypocholesterolemic effect of sericin-derived oligopeptides in high-cholesterol fed rats.Dietary phospholipids and intestinal cholesterol absorption.Nonalcoholic fatty liver disease: from lipid profile to treatment.Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials.A consensus statement on lipid management after acute coronary syndrome.Dietary calcium decreases plasma cholesterol by down-regulation of intestinal Niemann-Pick C1 like 1 and microsomal triacylglycerol transport protein and up-regulation of CYP7A1 and ABCG 5/8 in hamsters.
P2860
Q24597997-86EFEDE9-76D6-4A90-B293-6E4717B39F81Q26738307-354431F5-AD2C-48AB-91E1-81A7BA89FD13Q28485973-C4ED4E04-AF14-4FDE-9967-D14FEF734D1CQ33784552-04416B5E-49B3-4ED0-93BD-A21D5374E902Q34019608-72CCF831-9DEC-4B7A-9FBD-19F741D3F438Q34021021-5DDEAC0F-BD0E-4321-BE2C-F95AE714BF61Q34222252-5733E23B-942C-4CE1-AA9D-5CF2F4851367Q34238886-6B4A72F8-669A-47B9-B0E8-16BF28C6FDEEQ34550779-9177E99B-A229-48BA-B085-87BBCD083E23Q34554435-A3B73132-245E-43DF-B992-C0E7DE1BE2F4Q34606333-F7803BF8-E961-4632-88BC-60231EA95628Q34955169-7F7AAACE-25D9-4ADE-849A-F17460D18EE3Q34980363-1C3C5859-4BAD-4155-A1EA-3370933D7606Q35173623-2EEF08DF-3A7A-4B8D-81DC-37B10E076E2CQ35173650-B244F463-B8F5-441A-A784-549F7ADF459BQ35589013-BEC5E08D-A7AB-4F5A-BA39-34628DC3DACFQ36020286-246D4864-29B1-4127-9EA7-2303992A5C04Q36093336-F66194E6-1ED3-4A25-A893-17CE98064C8FQ36175641-64E9E3E5-DD52-4EBD-A47D-480C44BC8B22Q36206695-2560608A-B31B-4B72-B2A7-A08ABA2F6C92Q36367670-54A04B99-0B73-43A8-A245-65EC58B1C9F1Q37707904-2FCA2F94-934F-4ED2-B939-EB8F2F643288Q37794308-CC4E3F46-9302-4CCE-B634-8C64AB164A2AQ37824292-EA754F66-E0F2-45FA-9B0B-7596B3C1FF0DQ38036194-5BBFFE8A-51E9-4583-8FB4-E98C860B6523Q38287064-C5824170-E301-4EE1-BBE5-8CF8ED85D144Q38891202-E46F9BA0-DCE8-49E9-812B-3ABA7511633DQ39257875-A843DEA0-436F-4CAD-BC9B-3E4A3DE79485Q40378508-9C4A7E8A-B9B2-4FFC-8756-CF1BE19B26C6Q40729988-24F5514D-9433-45E2-BC0C-D061F628CC71Q41967024-596993D8-C0A0-4D70-A55C-71523DC9F6E2Q42852539-DB586114-A9A5-4FD6-806B-D618CE87E1DFQ50547169-5D22235C-2C53-4977-AE18-3E4635AD6926Q51772227-548BA533-44B9-4A59-B366-26AA3F7EB3AE
P2860
Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
@en
Niemann-Pick C1 Like 1
@nl
type
label
Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
@en
Niemann-Pick C1 Like 1
@nl
prefLabel
Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
@en
Niemann-Pick C1 Like 1
@nl
P1476
Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
@en
P2093
Harry R Davis
Scott W Altmann
P304
P356
10.1016/J.BBALIP.2009.01.002
P407
P577
2009-01-19T00:00:00Z